Status:
UNKNOWN
Outcome of Cerebral Venous Sinuses Stenting on Idiopathic Intracranial Hypertension
Lead Sponsor:
Al-Azhar University
Conditions:
Idiopathic Intracranial Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the work is to asses the positive effect of stenotic sinus segment stenting on idiopathic intracranial hypertension with headache and papilloedema.
Detailed Description
Participants The study will include group of patients with an established diagnosis of idiopathic intracranial hypertenton meeting our inclusion criteria and will admitted to Al-Azher Univerity Hospit...
Eligibility Criteria
Inclusion
- 1\. Grade II paplledema . 2. normal neurological examination except for six nerve palsy. 3. neuroimaging criteria of normal brain parenchyma without evidence of hydrocephalus, mass or structural lesion and no abnormal meningeal enhancement on MRI. 4. normal CSF composition. 5. elevated lumbar puncture opening pressure, defined as greater than or equal to 250 mmH2O in adults
Exclusion
- 1\. Age less than to 18 years. 2. creatinine .1.5 mg/dL. 3. severe allergic reaction to iodine contrast. 4.contraindication to general anesthesia, use of aspirin, clopidogrel or anticoagulants, thrombophilic disorder or anticardiolipin syndrome. 5. dural arteriovenous fistula or other arteriovenous lesion affecting cortical venous flow. 6. pregnancy.
Key Trial Info
Start Date :
March 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 5 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05308823
Start Date
March 15 2022
End Date
September 5 2022
Last Update
April 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Azher Univerity Hospitals (Al-Hussien and Bab El-Shaeria)
Cairo, Egypt